LifeStance Health (LFST) Accumulated Expenses (2020 - 2026)

LifeStance Health has disclosed Accumulated Expenses across 7 years of filings, most recently posting $117.3 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 17.4% year-over-year to $117.3 million; the TTM figure through Mar 2026 stood at $117.3 million (up 17.4% YoY), while the FY2025 annual figure was $143.3 million, up 22.02% from the prior year.
• Accumulated Expenses eased to $117.3 million in Q1 2026, from $143.3 million in the prior quarter.
• Over the last five years, Accumulated Expenses for LFST reached as high as $143.3 million in Q4 2025 and fell as low as $61.2 million in Q2 2022.
• The 5-year median for Accumulated Expenses is $100.4 million (2024), against an average of $98.7 million.
• Annual changes were most pronounced in 2024 — Accumulated Expenses surged 51.06% — and 2025, when it slipped 0.51%.
• A 5-year view of Accumulated Expenses shows it stood at $75.6 million in 2022, then surged by 35.46% to $102.5 million in 2023, then gained by 14.62% to $117.5 million in 2024, then grew by 22.02% to $143.3 million in 2025, then declined by 18.15% to $117.3 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $117.3 million, $143.3 million, and $113.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.